Announced

Completed

GE Healthcare completed the acquisition of Zionexa.

Synopsis

GE Healthcare, a subsidiary of American multinational conglomerate General Electric, completed the acquisition of Zionexa, an innovative company developing and commercializing molecular imaging solutions. Financial terms were not disclosed. “Like GE Healthcare, Zionexa’s products are aimed at enabling more precise diagnosis, improved treatment decision-making and ultimately better clinical outcomes for patients. This acquisition further demonstrates our commitment to enabling precision health and providing innovations that support oncologists, nuclear medicine specialists and other physicians throughout a cancer patient’s journey, from initial screening and diagnosis to informing therapy selection and monitoring the effectiveness of treatment," Kevin O’Neill, GE Healthcare President and CEO.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - GE Healthcare completed the acquisition of Zionexa.